S100 Family: 3.30.160.60.1.1.1.1

Representative domain: 1llmC01

Classification Lineage (3.30.160.60.1.1.1.1)

CATH Code	Level Description	Links
3	Alpha Beta
3.30	2-Layer Sandwich
3.30.160	Double Stranded RNA Binding Domain
3.30.160.60	Classic Zinc Finger	Gene3D
3.30.160.60.1
3.30.160.60.1.1
3.30.160.60.1.1.1
3.30.160.60.1.1.1.1

Summary of Non-Redundant Representatives


-	-	-	-	-	-	-	-	15

Non-Redundant Representatives (15)
Functional Families
Help

What is a Non-Redundant Representative?

CATH is a tree-like organisation of nodes that begins with the class node (i.e. the first branch-point of the tree) and ends with the domain nodes (i.e. the leaves of the tree). Each node below the class have a parent that they belong to, e.g. the parent of the H level (Homologous superfamily) is the T (Topology). Additionally, each node above the domains have child nodes that belong to them, e.g. the child nodes of a given H (Homologous superfamily) level are the S35 families (domains clustered at > 35% sequence identity).

S100 Count Entries in S100 Family 3.30.160.60.1.1.1.1 (15)

CATH code	Domain ID	Keywords
3.30.160.60.1.1.1.1.1	1llmC01	early growth response protein 1, Saccharomyces cerevisiae, Prion diseases, negative regulation of transcription from RNA polymerase II promoter, response to insulin stimulus, establishment of protein localization, positive regulation of RNA polymerase II transcriptional preinitiation complex assembly, BMP signaling pathway, General control protein GCN4, nucleus, positive regulation of transcription initiation from RNA polymerase II promoter, T cell differentiation, sequence-specific DNA binding transcription factor activity, general control protein GCN4, transcription activator activity, Mus musculus, negative regulation of gene-specific transcription from RNA polymerase II promoter, specific RNA polymerase II transcription factor activity, response to glucose stimulus, Early growth response protein 1, cellular response to protein stimulus, positive regulation of gene-specific transcription from RNA polymerase II promoter, sequence-specific DNA binding
3.30.160.60.1.1.1.1.2	1llmD01	establishment of protein localization, General control protein GCN4, nucleus, positive regulation of transcription initiation from RNA polymerase II promoter, positive regulation of RNA polymerase II transcriptional preinitiation complex assembly, BMP signaling pathway, Prion diseases, Saccharomyces cerevisiae, negative regulation of transcription from RNA polymerase II promoter, early growth response protein 1, response to insulin stimulus, response to glucose stimulus, Early growth response protein 1, cellular response to protein stimulus, negative regulation of gene-specific transcription from RNA polymerase II promoter, specific RNA polymerase II transcription factor activity, sequence-specific DNA binding, positive regulation of gene-specific transcription from RNA polymerase II promoter, sequence-specific DNA binding transcription factor activity, T cell differentiation, transcription activator activity, Mus musculus, general control protein GCN4
3.30.160.60.1.1.1.1.3	1a1hA02	response to glucose stimulus, Early growth response protein 1, cellular response to protein stimulus, transcription activator activity, Mus musculus, T cell differentiation, sequence-specific DNA binding transcription factor activity, BMP signaling pathway, nucleus, response to insulin stimulus, early growth response protein 1, Prion diseases, negative regulation of transcription from RNA polymerase II promoter
3.30.160.60.1.1.1.1.4	1a1iA02	Mus musculus, transcription activator activity, sequence-specific DNA binding transcription factor activity, T cell differentiation, Early growth response protein 1, cellular response to protein stimulus, response to glucose stimulus, response to insulin stimulus, negative regulation of transcription from RNA polymerase II promoter, Prion diseases, early growth response protein 1, nucleus, BMP signaling pathway
3.30.160.60.1.1.1.1.5	1aayA02	early growth response protein 1, negative regulation of transcription from RNA polymerase II promoter, Prion diseases, response to insulin stimulus, BMP signaling pathway, nucleus, T cell differentiation, sequence-specific DNA binding transcription factor activity, Mus musculus, transcription activator activity, Early growth response protein 1, cellular response to protein stimulus, response to glucose stimulus
3.30.160.60.1.1.1.1.6	1jk2A02	BMP signaling pathway, nucleus, early growth response protein 1, negative regulation of transcription from RNA polymerase II promoter, Prion diseases, response to insulin stimulus, Early growth response protein 1, cellular response to protein stimulus, response to glucose stimulus, T cell differentiation, sequence-specific DNA binding transcription factor activity, Mus musculus, transcription activator activity
3.30.160.60.1.1.1.1.7	1a1gA02	Mus musculus, transcription activator activity, sequence-specific DNA binding transcription factor activity, T cell differentiation, Early growth response protein 1, cellular response to protein stimulus, response to glucose stimulus, response to insulin stimulus, negative regulation of transcription from RNA polymerase II promoter, Prion diseases, early growth response protein 1, nucleus, BMP signaling pathway
3.30.160.60.1.1.1.1.8	1a1kA02	response to insulin stimulus, early growth response protein 1, negative regulation of transcription from RNA polymerase II promoter, Prion diseases, BMP signaling pathway, nucleus, Mus musculus, transcription activator activity, T cell differentiation, sequence-specific DNA binding transcription factor activity, Early growth response protein 1, cellular response to protein stimulus, response to glucose stimulus
3.30.160.60.1.1.1.1.9	1jk1A02	Prion diseases, negative regulation of transcription from RNA polymerase II promoter, early growth response protein 1, response to insulin stimulus, nucleus, BMP signaling pathway, sequence-specific DNA binding transcription factor activity, T cell differentiation, transcription activator activity, Mus musculus, response to glucose stimulus, Early growth response protein 1, cellular response to protein stimulus
3.30.160.60.1.1.1.1.10	1a1jA02	Prion diseases, negative regulation of transcription from RNA polymerase II promoter, early growth response protein 1, response to insulin stimulus, nucleus, BMP signaling pathway, sequence-specific DNA binding transcription factor activity, T cell differentiation, transcription activator activity, Mus musculus, response to glucose stimulus, Early growth response protein 1, cellular response to protein stimulus
3.30.160.60.1.1.1.1.11	1a1fA02	nucleus, BMP signaling pathway, response to insulin stimulus, negative regulation of transcription from RNA polymerase II promoter, Prion diseases, early growth response protein 1, Early growth response protein 1, cellular response to protein stimulus, response to glucose stimulus, Mus musculus, transcription activator activity, sequence-specific DNA binding transcription factor activity, T cell differentiation
3.30.160.60.1.1.1.1.12	1zaaC02	transcription activator activity, Mus musculus, T cell differentiation, sequence-specific DNA binding transcription factor activity, response to glucose stimulus, Early growth response protein 1, cellular response to protein stimulus, response to insulin stimulus, early growth response protein 1, Prion diseases, negative regulation of transcription from RNA polymerase II promoter, BMP signaling pathway, nucleus
3.30.160.60.1.1.1.1.13	1p47A02	Mus musculus, transcription activator activity, T cell differentiation, sequence-specific DNA binding transcription factor activity, Early growth response protein 1, cellular response to protein stimulus, response to glucose stimulus, response to insulin stimulus, early growth response protein 1, negative regulation of transcription from RNA polymerase II promoter, Prion diseases, BMP signaling pathway, nucleus
3.30.160.60.1.1.1.1.14	1p47B02	transcription activator activity, Mus musculus, T cell differentiation, sequence-specific DNA binding transcription factor activity, response to glucose stimulus, Early growth response protein 1, cellular response to protein stimulus, response to insulin stimulus, early growth response protein 1, Prion diseases, negative regulation of transcription from RNA polymerase II promoter, BMP signaling pathway, nucleus
3.30.160.60.1.1.1.1.15	1a1lA02	response to insulin stimulus, negative regulation of transcription from RNA polymerase II promoter, Prion diseases, early growth response protein 1, nucleus, BMP signaling pathway, Mus musculus, transcription activator activity, sequence-specific DNA binding transcription factor activity, T cell differentiation, Early growth response protein 1, cellular response to protein stimulus, response to glucose stimulus

The information on Functional Families (FunFams) is currently being updated and will be released by the end of March 2012. The pages will include the following features:

Multiple alignments for each functional family
Representative structure for each functional with known catalytic and interface residues highlighted, along with conserved residues predicted by scorecons
Detailed functional information on diversity and conservation within Functional families
Multi-domain architectures

In the meantime, please find a summary of information on the FunFams and protein networks within this superfamily on the Gene3D pages:

http://gene3d.biochem.ucl.ac.uk/superfamily/?accession=3.30.160.60.1.1.1.1

What is a Non-Redundant Representative?

Why can't I have a multiple structural alignment of the whole superfamily?

The simple answer is that some of the larger superfamilies in CATH comprise relatives which are very structurally diverse, having different secondary structure embellishments. Attempting to provide a global alignment of all domains in the superfamily would result in poor quality alignments. As a result, structural alignments in CATH are generated by first clustering together the structures that have at least some recognisable structural similarity using a normalised RMSD score (SIMAX = RMSDxNumber of residues in the largest domain/number of aligned residues) less than a given cutoff.

What is an Close Structural Cluster?

A Close Structural Cluster describes a cluster of two or more CATH domains that have been grouped together due to their close structural similarity (SIMAX score < 5Å where SIMAX = RMSD x Number of residues in the larger domain/number of aligned residues).

What is a Distant Structural Cluster?

A Distant Structural Cluster describes a cluster of two or CATH domains that have been grouped together with a more relaxed structural similarity threshold to investigate more distant evolutionary similarities (SIMAX score < 5Å where SIMAX = RMSD x Number of residues in the larger domain/number of aligned residues).

What is a Structural Neighbour?

The term "structural neighbour" is used here to describe two CATH domains that share a degree of structural similarity. The SSAP algorithm is used to calculate this similarity and works by generating a structure-based pairwise alignment of the two domains then scoring this alignment using a RMSD score which has been normalised by the length of the larger domain divided by the number of aligned residues (SIMAX).

S100 Family: 3.30.160.60.1.1.1.1

Classification Lineage (3.30.160.60.1.1.1.1)

Summary of Non-Redundant Representatives

What is a Non-Redundant Representative?

S100 Count Entries in S100 Family 3.30.160.60.1.1.1.1 (15)

What is a Non-Redundant Representative?

Why can't I have a multiple structural alignment of the whole superfamily?

What is an Close Structural Cluster?

What is a Distant Structural Cluster?

What is a Structural Neighbour?

CATH Shortcuts